Gsk (GSK) EBITDA Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Gsk (GSK) EBITDA Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Asml Holding | 618.86 Bn | 602.88 Bn | 5.90 Bn | - |
| 2 | Hsbc Holdings | 361.40 Bn | 361.40 Bn | - | - |
| 3 | General Electric | 329.38 Bn | 320.03 Bn | 6.95 Bn | 2,417.00 |
| 4 | Astrazeneca | 253.73 Bn | 248.44 Bn | 12.86 Bn | -200.00 |
| 5 | Citigroup | 228.07 Bn | -2,074.24 Bn | 24.75 Bn | 1,243.00 |
| 6 | Bhp | 216.09 Bn | 197.55 Bn | - | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - | - |
| 8 | Diageo | 197.36 Bn | 195.32 Bn | - | - |
| 9 | Unilever | 139.15 Bn | 132.12 Bn | - | - |
| 10 | Gsk | 101.53 Bn | 101.53 Bn | 15.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,411.00 |
| Mar 31, 2026 | 10.00 |
| Dec 31, 2025 | 345.00 |
| Sep 30, 2025 | 1,513.00 |
| Jun 30, 2025 | 973.00 |
| Mar 31, 2025 | -241.00 |
| Dec 31, 2024 | -204.00 |
| Sep 30, 2024 | -1,846.00 |
| Jun 30, 2024 | -96.00 |
| Mar 31, 2024 | -324.00 |
| Dec 31, 2023 | 51,339.00 |
| Jun 30, 2023 | -755.00 |
| Mar 31, 2023 | 780.00 |
| Dec 31, 2022 | 507.00 |
| Sep 30, 2022 | -766.00 |
| Jun 30, 2022 | -340.00 |
| Mar 31, 2022 | 1,325.00 |
| Dec 31, 2021 | -454.00 |
| Sep 30, 2021 | -278.00 |
| Jun 30, 2021 | 1,118.00 |